id: healthcare_access_barriers_to_undetected_peripheral_neuropathy
name: Healthcare Access Barriers to Neurophysiological Testing â†’ Undetected Peripheral
  Neuropathy
from_node:
  node_id: healthcare_access_barriers
  node_name: Healthcare Access Barriers to Neurophysiological Testing
to_node:
  node_id: undetected_peripheral_neuropathy
  node_name: Undetected Peripheral Neuropathy
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Neurophysiological confirmation of peripheral nerve damage is costly and
  sometimes involves invasive procedures'
- 'Step 2: Cost and invasiveness create barriers to accessing neurophysiological testing
  in resource-limited settings'
- 'Step 3: Without access to gold-standard testing, peripheral neuropathy in patients
  with AUD may remain undetected'
- 'Step 4: Clinical scales can serve as accessible alternatives but are underutilized
  when neurophysiological testing is unavailable'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Michail Papantoniou et al. 2024. "The Detection of Peripheral
    Neuropathy by Clinical Scales in Patients Diagnosed With Alcohol Use Disorder.."
    *Cureus*. https://doi.org/10.7759/cureus.70941
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.279811'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: clinical_scale_availability
  direction: weakens
  strength: strong
  description: When clinical scales like NIS and NSS are available and utilized as
    screening tools, the barrier to detecting neuropathy is reduced even in the absence
    of neurophysiological testing
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/healthcare_access/healthcare_access_barriers_to_undetected_peripheral_neuropathy.yaml
_category: healthcare_access
